Simrat Randhawa, EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 23,124 shares at $105.19 ($2.5M) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($2.5M) by EVP, Head of R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.19 | 2,600 | $273K | 11.1% |
| 2 | $106.25 | 7,215 | $767K | 31.2% |
| 3 | $106.74 | 13,309 | $1.4M | 57.7% |
| Total | $106.41 avg | 23,124 | $2.5M | 100% |
| Filing → |
| DNTH | SELL | 2025-11-14 | $14.8M | — | Filing → |
| DNTH | BUY | 2023-09-25 | $53K | — | Filing → |